Drug makers Cipla (down 1.9 percent) and Lupin (down 0.7 percent) were under pressure as both will be dropped from the index. ...http://www.moneycontrol.com/news/buzzing-stocks/yes-bank-indusind-bank-correct-1-2inclusionbse-sensex-cipla-lupin-weak_10085121.html
The company has received final approval from the USFDA to market a generic version of Astrazeneca's Pulmicort Respules. SI Reporter | Mumbai Last... ...http://www.business-standard.com/article/markets/cipla-gains-3-on-final-approval-for-generic-pulmicort-respules-117111700333_1.html
MUMBAI: Three days before Dr. Reddy's Laboratories Ltd announced quarterly results this summer, a message circulated on a private WhatsApp group... ...http://www.sify.com/finance/prescient-messages-about-indian-companies-circulate-in-whatsapp-groups-news-crime-rlqlGWafajbbd.html
The company plans to either acquire a company in China or collaborate with a local partner for this. ...http://www.moneycontrol.com/news/business/cipla-plans-to-enter-china39s-branded-respiratory-businesscoming-quarters_10020841.html
CNX Pharma gained close to 1 percent led by Cipla, Sun Pharma and Aurobindo Pharma while Bharti Airtel, Axis Bank, Lupin, Yes Bank and Reliance... ...http://www.moneycontrol.com/news/local-markets/market-update-cipla-gains-over-3-axis-bank-hits-52-week-high-bharti-airtel-most-active_10017401.html
Gefitinib 250mg tablets are an...
Rosuvastatin Calcium 40mg tablets...
Discover the difference with...